Dyne Therapeutics Cash Flow Statement 2019-2024 | DYN

Fifteen years of historical annual cash flow statements for Dyne Therapeutics (DYN).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-235.94$-168.10$-149.29$-59.44$-14.86
$0.57$2.96$3.67$0.78$0.27
$20.90$16.87$16.80$7.04$1.35
$21.47$19.83$20.47$7.82$1.62
$0$0$0$0$0
$0$0$0$0$0
$22.97$-1.24$13.70$8.57$1.69
$3.34$-4.14$-4.45$-3.46$-0.28
$26.31$-5.38$9.26$5.11$1.41
$-188.16$-153.65$-119.56$-46.51$-11.83
$-0.73$-3.07$-3.62$-1.16$-1.65
$0$0$0$0$0
$0$0$0$0$0
$-44.26$-121.18$-236.72$-44.50$0
$128$211$102$0$0
$84.04$90.27$-134.27$-44.50$0
$0$0$0$0$0
$83.31$87.20$-137.89$-45.66$-1.65
$0$0$0$-0.06$0
$0$0$0$0$0
$0$0$0$-0.06$0
$54.32$37.39$158$246$0
$54.32$37.39$158$381$19.99
$0$0$0$0$0
$0$0$0$-0.45$0
$54.32$37.39$158$381$19.99
$-50.53$-29.05$-99.63$289$6.51
$19.97$15.18$17.54$6.59$0.03
$0$0$0$0$0